This disease characteristic was also observed in AD mouse models, bearing mutations in APP and/or tau protein, in which mitochondrial dysfunction is already obvious before the appearance of Aβ deposits, NFT formation, and cognitive impairments (reviewed in [10]). This evidence concerns the gene MAPT and Alzheimer disease.